Determination of the solubility of rivaroxaban (anticoagulant drug, for the treatment and prevention of blood clotting) in supercritical carbon dioxide: Experimental data and correlations

نویسندگانغلامحسین صدیفیان,محمدمهدی بهوندیوسفی,فریبا رزمی منش,ارمین روشن قیاس
نشریهArabian Journal of Chemistry
شماره صفحات1
شماره مجلد15
ضریب تاثیر (IF)ثبت نشده
نوع مقالهFull Paper
تاریخ انتشار2022-11-16
رتبه نشریهعلمی - پژوهشی
نوع نشریهالکترونیکی
کشور محل چاپایران
نمایه نشریهSCOPUS ,JCR

چکیده مقاله

Supercritical processes are utilized in pharmaceutical, chemical, agricultural and food industries. To design the micro or nanoparticles formation processes via a supercritical fluid (SCF), it is necessary to have available the solubility data of a solid solute in a solvent such as supercritical carbon dioxide (SC-CO_2). In this article, the solubility of rivaroxaban (anticoagulant drug, for the treatment and prevention of blood clotting) in SC-CO_2 was investigated for the first time. Six semi-empirical models (Chrastil, Bartle, Jouyban, Garlapati and Madras, and Sodeifian) and two equation of states (EoSs) including Peng-Robinson (PR) and Soave-Redlich-Kwong (SRK) with twin-parametric van der Waals (vdW2) and covolume dependent (CVD) mixing rules were used to examine the correlation of drug solubility data. The best performance was obtained by semi-empirical Jouyban model (Average absolute relative deviation (AARD=12.436%)) and PR-vdW2 EoS (AARD=5.104%). Total and vaporization enthalpies were calculated 43.617 KJ.mol-1 and 63.288 KJ.mol-1, respectively.

tags: Supercritical carbon dioxide, Rivaroxaban, Solubility, Peng-Robinson, Sodeifian model, Soave-Redlich-Kwong.